1991 Memo Warned of Mercury in Shots. Page 1 of 2
1991 Memo Warned of Mercury in Shots. Page 1 of 2
1991 Memo Warned of Mercury in Shots. Page 1 of 2
A memo from Merck & Co. shows that, nearly a decade before the first public disclosure, senior
executives were concerned that infants were getting an elevated dose of mercury in vaccinations
containing a widely used sterilizing agent.
The March 1991 memo, obtained by The Times, said that 6-month-old children who received their shots
on schedule would get a mercury dose up to 87 times higher than guidelines for the maximum daily
consumption of mercury from fish.
"When viewed in this way, the mercury load appears rather large," said the memo from Dr. Maurice R.
Hilleman, an internationally renowned vaccinologist. It was written to the president of Merck's vaccine
division.
The memo was prepared at a time when U.S. health authorities were aggressively expanding their
immunization schedule by adding five new shots for children in their first six months. Many of these
shots, as well as some previously included on the vaccine schedule, contained thimerosal, an
antibacterial compound that is nearly 50% ethyl mercury, a neurotoxin.
Federal health officials disclosed for the first time in 1999 that many infants were being exposed to
mercury above health guidelines through routine vaccinations. The announcement followed a review by
the U.S. Food and Drug Administration that was described at the time as a first effort to assess the
cumulative mercury dose.
But the Merck memo shows that at least one major manufacturer was aware of the concern much earlier.
"The key issue is whether thimerosal, in the amount given with the vaccine, does or does not constitute a
safety hazard," the memo said. "However, perception of hazard may be equally important."
MORE STORIES ABOUT
Health Hazards
Vaccines
Merck & Co Inc
Mercury (metal)
Merck officials would not discuss the contents of the memo, citing pending litigation.
Separately, the drug giant is trying to fend off a legal onslaught over Vioxx, the popular painkiller it
introduced in 1999. The company, based in Whitehouse Station, N.J., faces hundreds of lawsuits
claiming that the drug caused heart problems and that Merck concealed the risks. Merck, which in
September pulled Vioxx off the market, has denied the allegations.
The legacy of thimerosal, meanwhile, also is causing problems for Merck and other drug companies.
More than 4,200 claims have been filed in a special federal tribunal, the Vaccine Injury Compensation
Program, by parents asserting that their children suffered autism or other neurodevelopmental
disorders from mercury in vaccines. A handful of similar claims are awaiting trial in civil courts. The
plaintiffs cite various scientific studies that they say prove the dangers of thimerosal, including at the
levels found in vaccines.
Thimerosal has been largely removed from pediatric vaccines in recent years in what health officials
have described as a precautionary measure. (This has been accomplished as drug makers have
voluntarily switched from multi-dose vials of vaccine, which require a chemical preservative like
thimerosal, to single-dose containers.)
converted by W eb2PDFConvert.com
In September, Gov. Arnold Schwarzenegger signed legislation prohibiting vaccines with more than trace
amounts of thimerosal from being given to babies and pregnant women. Iowa has a similar ban.
For their part, Merck and other vaccine makers, along with many government health officials and
scientists, say there is no credible evidence of harm from the amounts of mercury once widely present in
kids' shots. They cite a report in May by a committee of the national Institute of Medicine concluding
that the evidence "favors rejection of a causal relationship" between vaccines and autism.
The seven-page Merck memo was provided to The Times by James A. Moody, a Washington lawyer who
works with parent groups on vaccine safety issues. He said he obtained it from a whistle-blower whom he
would not name.
The memo provides the "first hard evidence that the companies knew -- or at least Merck knew -- that
the children were getting significantly more mercury" than the generally accepted dose, the lawyer said.
He also provided a copy to attorneys for Vera Easter, a Texas woman who blames thimerosal for the
condition of her 7-year-old son, Jordan, who is autistic and mentally retarded. The Easter lawsuit is
pending in U.S. District Court for the Eastern District of Texas. The defendants include Merck; rival
vaccine makers GlaxoSmithKline, Aventis Pasteur Inc. and Wyeth; and thimerosal developer Eli Lilly &
Co.
Easter's lawyer, Andy Waters, described the memo as "incredibly damning and incredibly significant."
After receiving it in the fall, he confronted Merck lawyers about why he hadn't seen it earlier.
In a letter to Waters in October, Merck attorneys said they had in fact made available 32 boxes of records,
but that the copying service hired by the plaintiffs for some reason had failed to copy several of the boxes
-- including the one with the Hilleman memo.
"The memo," said company spokeswoman Mary Elizabeth Blake, "was produced voluntarily by Merck in
the ordinary course of discovery proceedings."
1 | 2 | Next
From the Web
converted by W eb2PDFConvert.com
These 20 Scenes Caught On Google Street View Will Drop Your Jaw
Your Daily Dish
converted by W eb2PDFConvert.com
MORE:
Seizure Led to FloJo's Death
His 104 scores make his case
converted by W eb2PDFConvert.com
converted by W eb2PDFConvert.com